Connor, Clark & Lunn Investment Management Ltd. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$638,959
-17.5%
591,629
-1.5%
0.00%
-25.0%
Q2 2023$774,756
+0.6%
600,586
+2.9%
0.00%0.0%
Q1 2023$770,079
-10.4%
583,393
+1.9%
0.00%
-20.0%
Q4 2022$859,187
+3204.6%
572,791
+5549.9%
0.01%
Q3 2017$26,000
-92.6%
10,138
-92.1%
0.00%
-100.0%
Q2 2017$349,000
-50.4%
127,923
-39.8%
0.00%
-60.0%
Q1 2017$704,000
+28.0%
212,651
-8.0%
0.01%
+25.0%
Q4 2016$550,000
-53.2%
231,144
-27.8%
0.00%
-50.0%
Q3 2016$1,176,000
+22.8%
320,344
-25.4%
0.01%
+14.3%
Q2 2016$958,000
+7.3%
429,5440.0%0.01%0.0%
Q1 2016$893,000
-36.0%
429,544
-6.8%
0.01%
-41.7%
Q4 2015$1,396,000
+40.4%
460,672
+14.5%
0.01%
+50.0%
Q3 2015$994,000
+25.5%
402,450
+63.2%
0.01%
+14.3%
Q2 2015$792,000
+52.6%
246,600
+69.6%
0.01%
+75.0%
Q1 2015$519,000
+1107.0%
145,400
+661.3%
0.00%
Q4 2014$43,000
-53.8%
19,100
-11.6%
0.00%
-100.0%
Q1 2014$93,00021,6180.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders